SMS Pharmaceuticals Ltd — Call Transcript 2024

Feb 7, 2024

==> picture [240 x 160] intentionally omitted <==

Date: 07[th] February, 2024

To The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001.

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Security Code: 532815 Symbol: SMSPHARMA

Dear Sir/Madam,

Subject: Intimation of Investor’s Conference Call

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing here with invitation for Investor’s Conference Call, scheduled to be held on Monday, 12[th] February, 2024 at 04:00 P.M. (IST), to discuss the Company’s financial performance for the third quarter ended 31[st] December, 2023.

Please take into your records.

Thanking You, Yours faithfully,

For SMS PHARMACEUTICALS LIMITED

THIRUMALESH Digitally signed by THIRUMALESH TUMMA TUMMA Date: 2024.02.07 19:18:43 +05'30'

Thirumalesh Tumma Company Secretary

==> picture [165 x 71] intentionally omitted <==

SMS Pharmaceuticals Limited

Cordially invites you to

Conference Call

To discuss the financial performance for the Quarter ended 31[st] December, 2023

Day/Date : Monday, 12[th] February, 2024 Time : 04:00 PM, IST

Diamond Pass : Please Click Here to express join the Call

Primary Number:	+91 226280 1309
	+91 22 7115 8210
Toll Free Number:	Hongkong– 800964448
	Singapore– 8001012045
	UK– 08081011573
	US– 18667462133

Participants:

Mr. Vamsi Krishna Potluri: Executive Director

Mr. Lakshmi Narayana Tammineedi: Chief Financial Officer Mr. Thirumalesh Tumma: Company Secretary & Compliance Officer

We look forward to your participation

RSVP

Jigar Kavaiya / Parin Narichania, Strategic Growth Advisors Pvt. Ltd., Contact: +91 99206 02034/ 99300 25733